Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Spallanzani

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Minerva Chirurgica|February 12, 1998
[Rubber band ligation of hemorrhoids. Our experience]A Spallanzani, E Ricchi, A Carriero, et al.
Minerva Chirurgica|April 22, 1999
[Phantom rectum after Miles' operation]M Saviano, M Tedeschi, A Carriero, et al.
Minerva Chirurgica|June 1, 1997
[Surgery of anal fistulas]E Ricchi, A Carriero, A Spallanzani, et al.
Diseases of the Colon and Rectum|March 1, 1996
Vertical subcutaneous pedicle flaps for posterior perineal reconstruction. Report of three casesE Ricchi, S Fundarò, A Spallanzani, et al.
International Journal of Tissue Reactions|August 24, 2001
Cetirizine reduces the number of tryptase-positive mast cells in psoriatic patients: a double-blind controlled studyE Pestelli, M Caproni, B Giomi, et al.
International Journal of Cancer|March 30, 1999
Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesionsS Moretti, C Pinzi, A Spallanzani, et al.
Melanoma Research|August 1, 1997
In situ expression of transforming growth factor beta is associated with melanoma progression and correlates with Ki67, HLA-DR and beta 3 integrin expressionS Moretti, C Pinzi, E Berti, et al.
Diseases of the Colon and Rectum|March 24, 1998
Squamous-cell carcinoma developing within anal lichen planus: report of a caseS Fundarò, A Spallanzani, E Ricchi, et al.
Updates in Surgery|October 26, 2021
Strong impact of sarcopenia as a risk factor of survival in resected gastric cancer patients: first Italian report of a Bicentric studyA A Ricciardolo, N De Ruvo, F Serra, et al.
ESMO Open|February 26, 2026
Surrogate endpoints for survival in KEYNOTE-585: neoadjuvant/adjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy for gastric or gastroesophageal junction adenocarcinomaK Shitara, Y-J Bang, L S Wyrwicz, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Minerva Chirurgica|February 12, 1998
[Rubber band ligation of hemorrhoids. Our experience]A Spallanzani, E Ricchi, A Carriero, et al.
Minerva Chirurgica|April 22, 1999
[Phantom rectum after Miles' operation]M Saviano, M Tedeschi, A Carriero, et al.
Minerva Chirurgica|June 1, 1997
[Surgery of anal fistulas]E Ricchi, A Carriero, A Spallanzani, et al.
Diseases of the Colon and Rectum|March 1, 1996
Vertical subcutaneous pedicle flaps for posterior perineal reconstruction. Report of three casesE Ricchi, S Fundarò, A Spallanzani, et al.
International Journal of Tissue Reactions|August 24, 2001
Cetirizine reduces the number of tryptase-positive mast cells in psoriatic patients: a double-blind controlled studyE Pestelli, M Caproni, B Giomi, et al.
International Journal of Cancer|March 30, 1999
Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesionsS Moretti, C Pinzi, A Spallanzani, et al.
Melanoma Research|August 1, 1997
In situ expression of transforming growth factor beta is associated with melanoma progression and correlates with Ki67, HLA-DR and beta 3 integrin expressionS Moretti, C Pinzi, E Berti, et al.
Diseases of the Colon and Rectum|March 24, 1998
Squamous-cell carcinoma developing within anal lichen planus: report of a caseS Fundarò, A Spallanzani, E Ricchi, et al.
Updates in Surgery|October 26, 2021
Strong impact of sarcopenia as a risk factor of survival in resected gastric cancer patients: first Italian report of a Bicentric studyA A Ricciardolo, N De Ruvo, F Serra, et al.
ESMO Open|February 26, 2026
Surrogate endpoints for survival in KEYNOTE-585: neoadjuvant/adjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy for gastric or gastroesophageal junction adenocarcinomaK Shitara, Y-J Bang, L S Wyrwicz, et al.
Pageof 3